Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

May 01, 2007 (Vol. 27, No. 9)

BioSimilars Market Ripe for Expansion

Can Innovation in Drug Design Stem the Rising Tide?

  • Therapeutic proteins are a $60-billion industry. However, since 40% have lost their patent protection and more are soon to follow, producing biosimilars is now arousing great interest from generic manufacturers everywhere, warned Beatrice Muzard, equity analyst for pharmaceuticals at Ixis Corporate Solutions (www.cdcixis-cm.com), during the recent “BioSquare” conference held ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.